| Structure |
Chemical Name |
CAS |
MF |
 |
Tirofiban hydrochloride Impurity 6 |
2250244-31-4 |
C17H27NO7S2 |
 |
Demiditraz IMpurity |
944268-65-9 |
C20H20N2 |
 |
Aprepitant Impurity 16 |
850354-60-8 |
|
 |
Aripiprazole impurity 20 |
203395-83-9 |
|
|
|
Aripiprazole impurity 20 |
203395-83-9 |
|
|
|
Blonanserin impurity H |
|
|
|
|
Captopril impurity 1 |
|
|
|
|
Cefodizime Impurity 6 |
|
|
|
|
Clindamycin Impurity 5 |
|
|
|
|
Dapoxetine Impurity 16 |
|
|
|
|
Doxofylline Impurity 5 |
|
|
|
|
Everolimus impurity B |
|
|
|
|
FeBuxostat Impurity 27 |
|
|
 |
Fosaprepitant Impurity 1 |
172822-01-4 |
C23H22F7N4O6P |
 |
Hydroxychloroquine Impurity 7 |
47493-14-1 |
C20H28ClN3O2 |
 |
Indacaterol Impurity 12 |
1026461-20-0 |
C22H24N2O3 |
|
|
Isavuconazole Impurity 15 |
|
|
|
|
Isavuconazole Impurity 3 |
|
|
|
|
Isavuconazole Impurity 8 |
|
|
|
|
Lenvatinib Impurity 3 |
|
|
|
|
Linagliptin Impurity 44 |
|
|
|
|
MiraBegron impurity E |
|
|
|
|
Moxifloxacin Impurity 16 |
|
|
 |
Nifedipine Impurity H |
74936-71-3 |
C16H16N2O6 |
|
|
Plerixafor Impurity 3 |
|
|
|
|
Posaconazole Impurity 27 |
|
|
 |
Posaconazole Impurity 44 |
357189-97-0 |
C21H20F2N4O3 |
|
|
Pramipexole Impurity 10 |
|
|
|
|
rac N-Propyl-2-cyanimidopyrrolidine-5-acetic Acid |
|
|
|
|
sofosBuvir Impurity 33 |
|
|
|
|
sofosBuvir impurity 49 |
|
|
|
|
SofosBuvir Impurity 55 |
|
|
 |
Tenofovir Impurity W |
1244022-55-6 |
C15H24N5O8P |
|
|
TerButaline Ep Impurity B |
|
|
 |
Timolol EP Impurity H |
158636-97-6 |
C13H24N4O3S |
|
|
Tirofiban Impurity 11 |
|
|
 |
Tofacitinib Impurity 45 |
2407039-29-4 |
C16H20N6O2 |
|
|
Tofacitinib impurity S |
|
|
|
|
Trelagliptin Impurity 25 |
|
|
 |
Valaciclovir EP Impurity H |
84499-64-9 |
C11H16N6O4 |
 |
Lidocaine EP Impurity F |
142713-08-4 |
C14H22N2O |
|
|
Ampicillin Impurity P |
|
|
|
|
Cefdinir Impurity B (CP) |
|
|
|
|
Cloxacillin Impurity A |
|
|
 |
Erythromycin Impurity E(EP) |
857839-61-3 |
C37H65NO12 |
 |
Meropenem Trihydrate Impurity B |
166901-45-7 |
C34H50N6O10S2 |
 |
Oxacillin Sodium Impurity D(EP) |
1642559-63-4 |
C18H21N3O4S |
|
|
Oxacillin Sodium Impurity J(EP) |
|
|
|
|
Spectinomycin Impurity A |
|
|
 |
Eriodictyol-6-glucoside |
118040-45-2 |
C21H22O11 |
 |
Rubrofusarin triglucoside |
245724-07-6 |
C33H42O20 |
 |
Gabapentin EP Impurity G |
1500558-49-5 |
C10H19NO2 |
 |
2-butyrylbenzoic acid |
19666-03-6 |
C11H12O3 |
|
|
Cefminox sodium impurities D |
|
|
 |
Bisacodyl Related Compound B (20 mg) (2,4'-(Pyridin-2-ylmethylene)diphenol) |
16985-05-0 |
C18H15NO2 |
![Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride)](/CAS/20211123/GIF/4504-96-5.gif) |
Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride) |
4504-96-5 |
C18H20ClNO |
![Imiquimod Related Compound B (25 mg) (1-Isobutyl-1H-imidazo[4,5-c]quinoline 5-oxide)](/CAS/20150408/GIF/99010-63-6.gif) |
Imiquimod Related Compound B (25 mg) (1-Isobutyl-1H-imidazo[4,5-c]quinoline 5-oxide) |
99010-63-6 |
C14H15N3O |
![Ioversol Related Compound B (50 mg) (N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbamoyl)methoxy]-2,4,6-triiodoisophthalamide)](/CAS/20180808/GIF/104517-96-6.gif) |
Ioversol Related Compound B (50 mg) (N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbamoyl)methoxy]-2,4,6-triiodoisophthalamide) |
104517-96-6 |
C18H24I3N3O9 |
 |
Edoxaban Impurity 12 (1R,2R,4S) |
500572-10-1 |
C24H30ClN7O4S |
 |
paroxetine Mesylate |
217797-14-3 |
C20H24FNO6S |
 |
2-(2-Ethoxyphenoxy)ethyl Methanesulfonate |
169506-15-4 |
C11H16O5S |
 |
1-(5-(benzyloxy)-2-hydroxy-3-nitrophenyl)ethanone |
861841-94-3 |
C15H13NO5 |
|
|
acetylated penicilloic acids of piperacillin |
|
|
 |
Atorvastatin Dehydro Lactone |
442851-50-5 |
C33H31FN2O3 |
|
|
penicilloic acids of piperacillin |
|
|
|
|
RocuroniuMbroMide iMpurity B |
|
|
|
|
TetrazepaM IMp. C (EP): 7-Chloro-5-cyclohexyl-1-Methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
|
|
 |
bis(2-(7-Methoxynaphthalen-1-yl)ethyl)aMine |
1623104-92-6 |
C26H28ClNO2 |
|
|
bis(2-(7-Methoxynaphthalen-1-yl)ethyl)aMine |
1623104-92-6 |
C26H28ClNO2 |
![Methyl 2-oxo-3-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)Methyl)-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylate](/CAS/20130318/GIF/CB02611251.gif) |
Methyl 2-oxo-3-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)Methyl)-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylate |
1403474-78-1 |
C24H18N4O5 |
 |
Thiazolylacetyl glycine oxiMe |
178949-03-6 |
C7H8N4O4S |
 |
3-O-Decladinosyl-6-O-Methylerythronolide A |
118058-74-5 |
C30H55NO10 |
 |
Desmethyl Ranolazine |
755711-09-2 |
C23H31N3O3 |
![P-[[(1S)-2-(6-AMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-phosphonic Acid Monoethyl Ester](/CAS/GIF/1255525-18-8.gif) |
P-[[(1S)-2-(6-AMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-phosphonic Acid Monoethyl Ester |
1255525-18-8 |
C11H18N5O4P |
 |
DESVENLAFAXINE SUCCINATE |
448904-47-0 |
C20H31NO6 |
 |
Desloratadine IMpurity B |
117796-50-6 |
C19H19BrN2 |
|
|
Itraconazole IMpurity B |
|
|
 |
Benzene, 1-(3-chloropropyl)-3-(trifluoroMethyl)- |
82258-76-2 |
C10H10ClF3 |
![N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine](/CAS/GIF/1260614-73-0.gif) |
N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
1260614-73-0 |
C13H19N5 |
![2-(5-oxo-5H-chroMeno[2,3-b]pyridin-7-yl)propanoic acid](/CAS/GIF/52549-19-6.gif) |
2-(5-oxo-5H-chroMeno[2,3-b]pyridin-7-yl)propanoic acid |
52549-19-6 |
C15H11NO4 |
![1H-BenziMidazole, 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl]sulfinyl]-1-(2,2,2-trifluoroethyl)-](/CAS/GIF/1187926-84-6.gif) |
1H-BenziMidazole, 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl]sulfinyl]-1-(2,2,2-trifluoroethyl)- |
1187926-84-6 |
C18H15F6N3O2S |
 |
4,5-dihydro-a-(hydroxyMethyl)-a,3-diMethyl-5-oxo-1-phenyl-1H-Pyrazole-4-Methanesulfonic acid |
1242471-40-4 |
C13H16N2O5S |
![16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-17-(hydroxyMethyl)-D-hoMoandrosta-1,4-diene-3,17a-dione (Mixture of DiastereoMers)](/CAS/GIF/1040085-99-1.gif) |
16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-17-(hydroxyMethyl)-D-hoMoandrosta-1,4-diene-3,17a-dione (Mixture of DiastereoMers) |
1040085-99-1 |
C25H34O6 |
 |
2-BroMo-1-cyclopropyl-2-(3-fluorophenyl)ethanone |
1359829-72-3 |
C11H10BrFO |
 |
N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetaMide |
198471-06-6 |
C18H16N2O4S |
 |
N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
289472-81-7 |
C19H24N4O3 |
 |
(R)-5-chloro-N-(4-(3-oxomorpholino)phenyl)-N- ((2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide |
1879903-65-7 |
C19H18ClN3O5S |
 |
Cefmetazole impurity |
56796-19-1 |
C28H27N7O5S3 |
 |
3-ethylisobenzofuran-1(3H)-one |
17475-41-1 |
C10H10O2 |
 |
Ivabradine Impurity 21 HCl |
304465-03-0 |
C26H34N2O5 |
|
|
Moxifloxacin EP Impurity C HCl |
|
|
 |
Moxifloxacin Impurity 23 |
855661-74-4 |
C21H24FN3O4 |
 |
Solifenacin Related Compound 18 |
1225338-27-1 |
C23H26N2O2 |
 |
N-(2-hydroxy-3-(4-((2-isopropoxyethoxy)methyl)phenoxy)propyl) -N-isopropylformamide |
1447715-45-8 |
C19H31NO5 |
 |
Tofacitinib Related Compound |
1206824-85-2 |
C10H18ClN3O |
 |
Fluvastatin EP impurity A -G |
93957-58-5 |
C24H26FNO4 |
 |
PWKRNMKZGWGSDV-UHFFFAOYSA-N |
1422960-88-0 |
C33H34ClN4+ |
![sodium:(2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoate](/CAS/20180527/GIF/1329502-92-2.gif) |
sodium:(2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoate |
1329502-92-2 |
C33H41N4NaO7 |
 |
QFJAHHNMKTWTGZ-DZAPPIOQSA-N |
2045402-27-3 |
C35H36ClNO4S |
![N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-5,6,7,8-tetrahydro-1-naphthalenecarboxamide](/CAS/20200119/GIF/1374226-74-0.gif) |
N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-5,6,7,8-tetrahydro-1-naphthalenecarboxamide |
1374226-74-0 |
C18H24N2O |